In the study of Gutiérrez OM et al., the mortality rate of patients with a high-risk APOL1 genotype was significantly lower than that of patients with low-risk genotypes in the prognostic review cohort of chronic kidney disease [35]. The gene discussed is APOL1; the disease is chronic kidney disease.